CINEMARK USA INC /TX

Adoption of Rule 10b5-1 Trading Plans

On September 9, 2025, Sean Gamble, our President and Chief Executive Officer, adopteda trading plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934 to sell up to 182,661 shares of the Company’s common stock. The plan was adopted to facilitate the orderly sale of shares of the Company’s common stock for personal financial planning purposes and intended to satisfy the affirmative defense of Rule 10b5-1(c). The plan terminated on April 6, 2026, as all of the shares under the plan were sold.

On May 22, 2026, Mr. Gamble adopteda trading plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934 to sell up to 146,075 shares of the Company’s common stock owned by a family trust for which Mr. Gamble is a trustee. The plan was adopted to facilitate the orderly sale of shares of the Company’s common stock for personal financial planning purposes and intended to satisfy the affirmative defense of Rule 10b5-1(c). The plan is set to expire on April 23, 2027, or when all shares under the plan are sold.

On September 10, 2025, Melissa Thomas, our Chief Financial Officer, adopted a trading plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934 to sell up to 100,206 shares of the Company’s common stock. The plan was adopted to facilitate the orderly sale of shares of the Company’s common stock for personal financial planning purposes and is intended to satisfy the affirmative defense of Rule 10b5-1(c). The plan terminated on May 12, 2026, as all of the shares under the plan were sold.

On May 21, 2026, Ms. Thomas adopteda trading plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934 to sell up to 51,306 shares of the Company’s common stock. The plan was adopted to facilitate the orderly sale of shares of the Company’s common stock for personal financial planning purposes and intended to satisfy the affirmative defense of Rule 10b5-1(c). The plan is set to expire on March 5, 2027, or when all shares under the plan are sold.

On December 3, 2025, Mark Zoradi, adirector, adopted a trading plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934 to sell up to 150,000 shares of the Company’s common stock owned by a family trust for which Mr. Zoradi is a trustee. The plan was adopted to facilitate the orderly sale of shares of the Company’s common stock for personal financial planning purposes and intended to satisfy the affirmative defense of Rule 10b5-1(c). The plan terminated on May 1, 2026, as all of the shares under the plan were sold.

On May 21, 2026, Michael Cavalier, our Executive Vice President General Counsel & Business Affairs, Secretary, adopteda trading plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934 to sell up to 107,296 shares of the Company’s common stock owned by a family trust for which Mr. Cavalier is a trustee. The plan was adopted to facilitate the orderly sale of shares of the Company’s common stock for personal financial planning purposes and intended to satisfy the affirmative defense of Rule 10b5-1(c). The plan is set to expire on February 26, 2027, or when all shares under the plan are sold.

On June 11, 2026, Valmir Fernandes, our President of Cinemark International, adopteda trading plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934 to sell up to 58,000 shares of the Company’s common stock owned by a family trust for which Mr. Fernandes is a trustee. The plan was adopted to facilitate the orderly sale of shares of the Company’s common stock for personal financial planning purposes and intended to satisfy the affirmative defense of Rule 10b5-1(c). The plan is set to expire on March 31, 2027, or when all shares under the plan are sold.

Supplemental Schedules Specified by the Senior Notes Indentures

As required by the indentures governing CUSA’s 7.00% Senior Notes and 5.25% Senior Notes, collectively “the senior notes”, CUSA has included in this filing interim financial information for its subsidiaries that have been designated as unrestricted subsidiaries, as defined by the indentures. As required by these indentures, CUSA has included an unaudited condensed consolidating balance sheet and unaudited condensed consolidating statements of income, comprehensive income and cash flows for CUSA. See Liquidity and Capital Resourcesat Part I - Item 2 for discussion of the senior notes, including relevant covenants and restrictions. The following supplementary schedules separately identify CUSA’s restricted subsidiaries and unrestricted subsidiaries as required by the indentures.